Search Results 561-570 of 5853 for 搜索引擎在线咨询邮箱：lgooxc@hotmail.com
About this study. PSSc-001 (LOTUSS) This study is a Phase 2, multinational, open-label, randomized, parallel-group, safety and tolerability study of ...
Contact the Montori Knowledge and Evaluation Research Unit at Mayo Clinic about evidence-based medicine, patient empowerment, shared decision-making and ...
Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
About this study. The primary objective of this program is to provide Daclatasvir (DCV) for 24 weeks to be given in combination with Sofosbuvir (SOF) to ...
In this study the investigators propose to use a daily dose of 45 mg (30 mg at 8 AM and 15 mg at 4 PM). This relatively small well-tolerated dose is likely to ...
This study is designed to investigate the AliveCor's ability to record the heart's electrical activity similar to other lead configurations. Participation ...
About this study. Skeletal muscle abnormalities (sarcopenia) and frailty are common complications seen in patients with end-stage liver disease.
(Note: This email address is only for Mayo Clinic School of Graduate Medical Education and not for other Mayo Clinic College of Medicine and Science schools' ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.